Preeclampsia SFlt-1-PlGF Ratio - Pocket Card

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

Preeclampsia sFlt-1/PlGF ratio

A new biomarker to aid in the diagnosis of preeclampsia


Determination of the sFlt-1/PlGF ratio from gestational week 20+0
Suggested patient profile

1 Investigation OR 2 Pathological OR 3 One of the following risk factors


of suspected uterine artery • Preeclampsia in a previous pregnancy
preeclampsia Doppler • Preexisting hypertension
• Preexisting kidney disease
• Diabetes

Sample materials: Serum


sFlt-1/PlGF ratio – Aid in diagnosis of preeclampsia

Early-onset preeclampsia Late-onset preeclampsia Gestational


20 34 weeks
sFlt-1/PlGF Rule-in sFlt-1/PlGF
Rule-in specificity: 95.5 %
specificity: 99.5 % sensitivity: 58.2 %
110
sensitivity: 88.0 %
85 *

33 33
Rule-out Rule-out
specificity: 94.0 % specificity: 73.1 %
sensitivity: 95.0 % sensitivity: 89.5 %

* At a cut-off of 85 for the whole gestational period (from week 20+0 to delivery) the sensitivity was calculated at 82 % and the specificity at 95 %.

References
Verlohren, S., Galindo, A., Schlembach, D., Zeisler, H., Herraiz, I., Moertl, M. G., et al. (2010). An automated method for the determination
of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol. 202(2):161.e1-161.e11.
Study report: Diagnosis of Preeclampsia by means of the Elecsys® assays sFlt-1 and PlGF (2012); Data on file.

COBAS, ELECSYS and LIFE NEEDS ANSWERS are trademarks of Roche.


©2013 Roche · Roche Diagnostics International Ltd · CH-6343 Rotkreuz · Switzerland · www.cobas.com

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy